Oldest pages
Showing below up to 50 results in range #51 to #100.
- TCRγδ (20:28, 14 May 2023)
- HLA-DR (17:36, 16 May 2023)
- CD11b (16:31, 27 May 2023)
- CD15 (08:57, 30 May 2023)
- CD16 (13:29, 31 May 2023)
- IgM (11:57, 1 June 2023)
- CD24 (17:32, 7 June 2023)
- CD56 (12:20, 8 June 2023)
- CD57 (15:15, 11 June 2023)
- CD61 (22:01, 11 June 2023)
- Extra (19:53, 13 June 2023)
- CD3 (10:22, 14 June 2023)
- CD65 (14:26, 14 June 2023)
- CD235 (14:29, 14 June 2023)
- Key to marker expression table (20:00, 17 June 2023)
- CD2 (21:36, 17 June 2023)
- Monoclonal B lymphocytosis (21:26, 18 June 2023)
- Test open (10:43, 19 June 2023)
- Flow cytometric marker pattern of mantle cell lymphoma (11:53, 20 June 2023)
- Flow cytometric marker pattern of chronic lymphocytic leukaemia (22:44, 20 June 2023)
- NEW (11:33, 21 June 2023)
- Detailed description of individual markers used in diagnosis (13:37, 28 June 2023)
- Immunoglobulin light chains (20:31, 4 July 2023)
- FMC7 (20:33, 4 July 2023)
- TDT (20:34, 4 July 2023)
- MPO (20:34, 4 July 2023)
- CD5 (20:36, 4 July 2023)
- CD10 (20:36, 4 July 2023)
- CD13 (20:37, 4 July 2023)
- CD14 (20:38, 4 July 2023)
- CD19 (20:38, 4 July 2023)
- CD22 (20:39, 4 July 2023)
- CD23 (20:40, 4 July 2023)
- CD25 (20:42, 4 July 2023)
- CD34 (20:43, 4 July 2023)
- CD38 (20:43, 4 July 2023)
- CD79a (20:44, 4 July 2023)
- CD79b (20:45, 4 July 2023)
- CD103 (20:45, 4 July 2023)
- CD117 (20:46, 4 July 2023)
- CD138 (20:47, 4 July 2023)
- CD200 (20:47, 4 July 2023)
- Alt (10:33, 6 July 2023)
- CD20 (12:58, 6 July 2023)
- Alt Alt (10:26, 10 July 2023)
- Summary tables comparing neoplastic disorders (10:29, 10 July 2023)
- Description of individual markers (09:23, 11 July 2023)
- Expression strength key (15:14, 11 July 2023)
- Flow cytometry: Mantle cell Lymphoma (15:18, 11 July 2023)
- Description of marker expression of specific disorders (13:21, 12 July 2023)